Información del artículo
El Texto completo está disponible en PDF
Referencias bibliográficas
[1.]
F.L. Altice, G.H. Friedland.
The era of adherence to HIV therapy.
Ann Intern Med, 129 (1998), pp. 503-505
[2.]
S. Mannheimer, G. Friedland, J. Matts, C. Child, M. Chesney.
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human mmunodeficiency virus-infected persons in clinical trials.
Clin Infect Dis, 34 (2002), pp. 1115-1121
[3.]
P. Nieuwkerk, E. Gisolf, M. Sprangers, S. Danner.
Adherence over 48 weeks in an antiretroviral clinical trial: Variable within patients, affected by toxicities and independently predictive of virological response.
Antivir Ther, 6 (2001), pp. 97-103
[4.]
H. Knobel, A. Guelar, A. Carmona, M. Espona, A. Gonzalez, J.L. Lopez-Colomes, et al.
Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.
AIDS Patient Care STDS, 15 (2001), pp. 193-199
[5.]
M.V. Le, G. Chene, M.P. Carrieri, A. Alioum, F. Brun-Vezinet, L. Piroth, et al.
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen.
AIDS, 16 (2002), pp. 21-29
[6.]
L.G. Miller, R.D. Hays.
Measuring adherence to antiretroviral medications in clinical trials.
HIV Clin Trials, 1 (2000), pp. 36-46
[7.]
D.R. Bangsberg, F.M. Hecht, H. Clague, E.D. Charlebois, D. Ciccarone, M. Chesney, et al.
Provider assessment of adherence to HIV antiretroviral therapy.
J Acquir Immune Defic Syndr, 26 (2001), pp. 435-442
[8.]
R. Murri, A. Ammassari, K. Gallicano, A. De Luca, A. Cingolani, D. Jacobson, et al.
Patient-reported nonadherence to HAART is related to protease inhibitor levels.
J Acquir Immune Defic Syndr, 24 (2000), pp. 123-128
[9.]
S. Duran, C. Solas, B. Spire, M.P. Carrieri, J.G. Fuz, D. Costagliola, et al.
“Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?”. A comparison between patients’ self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
AIDS, 15 (2001), pp. 1075-1077
[10.]
J.F. Steiner, A.V. Prochaska.
The assessment of refill compliance using pharmacy records: Methods, validity, and applications.
J Clin Epidemiol, 50 (1997), pp. 105-116
[11.]
R.S. Hogg, K. Heath, D. Bangsberg, B. Yip, N. Press, M.V. O’Shaughnessy, et al.
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.
AIDS, 16 (2002), pp. 1051-1058
[12.]
D.L. Paterson, S. Swindells, J. Mohr, M. Brester, E.N. Vergis, C. Squier, et al.
Adherence to Protease Inhibitor therapy and outcomes in patients with HIV infection.
Ann Intern Med, 133 (2000), pp. 21-30
[13.]
S.G. Deeks.
Determinants of virologic response to antiretroviral therapy: Implications for long-term strategies.
Clin Infect Dis, 30 (2000), pp. S177-S184
[14.]
J.H. Arnsten, P.A. Demas, H. Farzadegan, R.W. Grant, M.N. Gourevitch, C.J. Chang, et al.
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparision of self-report and electronic monitoring.
Clin Infect Dis, 33 (2001), pp. 1417-1423
[15.]
J. Martin, I. Escobar, R. Rubio, G. Sabugal, J. Gascon, F. Pulido, et al.
Study of the validity of a Questionnaire to asses the adherence to therapy in patients infected by HIV.
HIV Clinical Trials, 2 (2001), pp. 31-37
[16.]
X. Gao, D.P. Nau.
Congruence of three self-report measures of medication adherence among HIV patients.
Ann Pharmacother, 34 (2000), pp. 1117-1122
[17.]
H. Knobel, J. Alonso, J. Casado, et al.
Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study.
AIDS, 16 (2002), pp. 605-613
[18.]
B.J. Turner.
Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
J Infect Dis, 185 (2002), pp. S143-S151
[19.]
H. Knobel, C. Codina, J.M. Miró, A. Carmona, B. García, A. Antela, et al.
Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia del tratamiento antirretroviral.
Enferm Infecc Microbiol Clin, 18 (2000), pp. 27-39
[20.]
H. Liu, C.E. Golin, L.G. Miller, R.D. Hays, C.K. Beck, S. Sanandaji, et al.
A comparison study of multiple measures of adherence to HIV protease inhibitors.
Ann Intern Med, 134 (2001), pp. 968-977
[21.]
C. Codina, M. Martinez, M. Tuset, E. Del Cacho, M.T. Martín, J.M. Miró, et al.
Comparación de tres métodos de cálculo de adherencia en pacientes con tratamiento antirretroviral.
Enferm Infecc Microbiol Clin, 20 (2002), pp. 484-490
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
